Class IIOngoingD-0689-2026
Drug recall · July 22, 2026
CLEVIPREX recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary, NC 27518, by Fresenius Kabi, Graz, Austria, NDC 10122-611-10.
- Lots / codes
Lot #: 1239521, 1237454, Exp. Date 10/2027
- Quantity
- 44280 vials
- Company
- Chiesi USA, Inc., Cary, NC
- Distribution
- Nationwide within the United States
- Initiated
- July 6, 2026 · Voluntary: Firm initiated
- Classified
- July 14, 2026
- Reported
- July 22, 2026
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.